Underwhelming margins at PayPal have been worrying analysts in recent quarters. The company#39;s low-margin business products have grown strongly, while growth in its branded products has slowed due to increased pressure from competitors like Apple.

Read More

​ Underwhelming margins at PayPal have been worrying analysts in recent quarters. The company#39;s low-margin business products have grown strongly, while growth in its branded products has slowed due to increased pressure from competitors like Apple. Underwhelming margins at PayPal have been worrying analysts in recent quarters. The company#39;s low-margin business products have grown strongly, while growth in its branded products has slowed due to increased pressure from competitors like Apple.  Moneycontrol Latest News Read More  

Underwhelming margins at PayPal have been worrying analysts in recent quarters. The company#39;s low-margin business products have grown strongly, while growth in its branded products has slowed due to increased pressure from competitors like Apple.

Someone looking for the longer term should ideally take advantage of correction rather than getting worried says Devang Mehta of Spark Private Wealth.

Read More

​ Someone looking for the longer term should ideally take advantage of correction rather than getting worried says Devang Mehta of Spark Private Wealth. Someone looking for the longer term should ideally take advantage of correction rather than getting worried says Devang Mehta of Spark Private Wealth.  Moneycontrol Latest News Read More  

Someone looking for the longer term should ideally take advantage of correction rather than getting worried says Devang Mehta of Spark Private Wealth.

SBFC Finance has seen consistent improvement in asset quality, with the gross non-performing assets in FY23 falling 31 basis points year-on-year to 2.43 percent

Read More

​ SBFC Finance has seen consistent improvement in asset quality, with the gross non-performing assets in FY23 falling 31 basis points year-on-year to 2.43 percent SBFC Finance has seen consistent improvement in asset quality, with the gross non-performing assets in FY23 falling 31 basis points year-on-year to 2.43 percent  Moneycontrol Latest News Read More  

SBFC Finance has seen consistent improvement in asset quality, with the gross non-performing assets in FY23 falling 31 basis points year-on-year to 2.43 percent

Chinese assets have gotten a boost in recent days amid a slew of promises from Beijing to spur growth and revitalize the nation’s flagging private sector.

Read More

​ Chinese assets have gotten a boost in recent days amid a slew of promises from Beijing to spur growth and revitalize the nation’s flagging private sector. Chinese assets have gotten a boost in recent days amid a slew of promises from Beijing to spur growth and revitalize the nation’s flagging private sector.  Moneycontrol Latest News Read More  

Chinese assets have gotten a boost in recent days amid a slew of promises from Beijing to spur growth and revitalize the nation’s flagging private sector.

Motilal Oswal Asset Management Company will merge its target maturity fund into a fund of funds investing in benchmark government security

Read More

​ Motilal Oswal Asset Management Company will merge its target maturity fund into a fund of funds investing in benchmark government security Motilal Oswal Asset Management Company will merge its target maturity fund into a fund of funds investing in benchmark government security  Moneycontrol Latest News Read More  

Motilal Oswal Asset Management Company will merge its target maturity fund into a fund of funds investing in benchmark government security

EBITDA or earnings before interest, tax, depreciation and amortization is expected to increase to Rs 965 crore for the quarter.

Read More

​ EBITDA or earnings before interest, tax, depreciation and amortization is expected to increase to Rs 965 crore for the quarter. EBITDA or earnings before interest, tax, depreciation and amortization is expected to increase to Rs 965 crore for the quarter.  Moneycontrol Latest News Read More  

EBITDA or earnings before interest, tax, depreciation and amortization is expected to increase to Rs 965 crore for the quarter.

EBITDA or earnings before interest, tax, depreciation and amortization is expected to increase to Rs 965 crore for the quarter.

Read More

​ EBITDA or earnings before interest, tax, depreciation and amortization is expected to increase to Rs 965 crore for the quarter. EBITDA or earnings before interest, tax, depreciation and amortization is expected to increase to Rs 965 crore for the quarter.  Moneycontrol Latest News Read More  

EBITDA or earnings before interest, tax, depreciation and amortization is expected to increase to Rs 965 crore for the quarter.

Fitch downgraded the United States to AA from AAA late on Tuesday, citing expected fiscal deterioration over the next three years as well as growing government debt. Fitch was the second major agency to cut the country#39;s rating. In 2011 Standard Poor#39;s stripped the country of its triple-A grade.

Read More

​ Fitch downgraded the United States to AA from AAA late on Tuesday, citing expected fiscal deterioration over the next three years as well as growing government debt. Fitch was the second major agency to cut the country#39;s rating. In 2011 Standard Poor#39;s stripped the country of its triple-A grade. Fitch downgraded the United States to AA from AAA late on Tuesday, citing expected fiscal deterioration over the next three years as well as growing government debt. Fitch was the second major agency to cut the country#39;s rating. In 2011 Standard Poor#39;s stripped the country of its triple-A grade.  Moneycontrol Latest News Read More  

Fitch downgraded the United States to AA from AAA late on Tuesday, citing expected fiscal deterioration over the next three years as well as growing government debt. Fitch was the second major agency to cut the country#39;s rating. In 2011 Standard Poor#39;s stripped the country of its triple-A grade.

Concord Biotech IPO | The issue comprises only an offer for sale (OFS) by Helix Investment Holdings Pte Limited, which is backed by Quadria Capital Fund LP, a healthcare-focused private equity fund in Asia.

Read More

​ Concord Biotech IPO | The issue comprises only an offer for sale (OFS) by Helix Investment Holdings Pte Limited, which is backed by Quadria Capital Fund LP, a healthcare-focused private equity fund in Asia. Concord Biotech IPO | The issue comprises only an offer for sale (OFS) by Helix Investment Holdings Pte Limited, which is backed by Quadria Capital Fund LP, a healthcare-focused private equity fund in Asia.  Moneycontrol Latest News Read More  

Concord Biotech IPO | The issue comprises only an offer for sale (OFS) by Helix Investment Holdings Pte Limited, which is backed by Quadria Capital Fund LP, a healthcare-focused private equity fund in Asia.

KR Choksey recommended accumulate rating on UPL with a target price of Rs 684 in its research report dated August 02 2023.

Read More

​ KR Choksey recommended accumulate rating on UPL with a target price of Rs 684 in its research report dated August 02 2023. KR Choksey recommended accumulate rating on UPL with a target price of Rs 684 in its research report dated August 02 2023.  Moneycontrol Latest News Read More  

KR Choksey recommended accumulate rating on UPL with a target price of Rs 684 in its research report dated August 02 2023.